{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:28:06Z","timestamp":1791260886812,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health and Social Care Research from Welsh government"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.semcdb.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T06:15:48Z","timestamp":1454825748000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer"],"prefix":"10.1016","volume":"52","author":[{"given":"Ellie","family":"Rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2016.02.007_bib0005","first-page":"259","article-title":"Translation of case reports in Ueber die multiplen Fibrome der Haut und ihre Beziehung zu den multiplen Neuromen by F. v. Recklinghausen","volume":"29","author":"Crump","year":"1981","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.ejhg.5201676","article-title":"Neurofibromatosis 1","volume":"15","author":"Ferner","year":"2007","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/2229-5178.115515","article-title":"Facial plexiform neurofibromatosis: a surgical challenge","volume":"4","author":"Dogra","year":"2013","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.3107130","article-title":"Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17","volume":"236","author":"Barker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0092-8674(87)90534-4","article-title":"Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene","volume":"49","author":"Seizinger","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0040","first-page":"721","article-title":"Refined physical and genetic mapping of the NF1 region on chromosome 17","volume":"45","author":"Fain","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.1320280333","article-title":"Cases of neurofibromatosis with rearrangements of chromosome 17 involving band 17q11.2","volume":"28","author":"Schmidt","year":"1987","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0168-9525(89)90085-1","article-title":"Progress towards identifying the neurofibromatosis (NF1) gene","volume":"5","author":"Collins","year":"1989","journal-title":"Trends Genet."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0888-7543(89)90053-0","article-title":"Characterization of a translocation within the von Recklinghausen neurofibromatosis region of chromosome 17","volume":"5","author":"Menon","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrc3911","article-title":"A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor","volume":"15","author":"Ratner","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0080","doi-asserted-by":"crossref","first-page":"R563","DOI":"10.1016\/j.cub.2005.07.010","article-title":"Signaling interplay in Ras superfamily function","volume":"15","author":"Mitin","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.4-3-263","article-title":"The molecular perspective: the ras oncogene","volume":"4","author":"Goodsell","year":"1999","journal-title":"Oncologist."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2015.06.003","article-title":"The RAS-binding domain of human BRAF protein serine\/threonine kinase exhibits allosteric conformational changes upon binding HRAS","author":"Aramini","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm3979","article-title":"Regulation of RAF protein kinases in ERK signalling","volume":"16","author":"Lavoie","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/humu.21405","article-title":"Structural and biochemical consequences of NF1 associated nontruncating mutations in the Sec14-pH module of neurofibromin","volume":"32","author":"Welti","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20050231","article-title":"Ras plasma membrane signalling platforms","volume":"389","author":"Hancock","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrm3255","article-title":"Regulating the regulator: post-translational modification of RAS","volume":"13","author":"Ahearn","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0120","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1101\/gad.1690808","article-title":"Tumorigenic activity and therapeutic inhibition of Rheb GTPase","volume":"22","author":"Mavrakis","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0125","first-page":"1","article-title":"mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","author":"Dodd","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0130","doi-asserted-by":"crossref","first-page":"39524","DOI":"10.1074\/jbc.M503707200","article-title":"The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway","volume":"280","author":"Ozawa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0135","doi-asserted-by":"crossref","first-page":"e47283","DOI":"10.1371\/journal.pone.0047283","article-title":"Nf1 RasGAP Inhibition of LIMK2 Mediates a New Cross-Talk between Ras and Rho Pathways","volume":"7","author":"Vall\u00e9e","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mcn.2009.07.014","article-title":"The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase\/cofilin pathway","volume":"42","author":"Starinsky-Elbaz","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01233074","article-title":"Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules","volume":"19","author":"Gregory","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mc.20552","article-title":"Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase","volume":"48","author":"Kweh","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0155","doi-asserted-by":"crossref","first-page":"16971","DOI":"10.1523\/JNEUROSCI.1756-12.2012","article-title":"Neurofibromin Mediates FAK Signaling in Confining Synapse Growth at Drosophila Neuromuscular Junctions","volume":"32","author":"Tsai","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-5793(03)01507-2","article-title":"PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin","volume":"557","author":"Feng","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0165","doi-asserted-by":"crossref","first-page":"9399","DOI":"10.1074\/jbc.M708206200","article-title":"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2","volume":"283","author":"Patrakitkomjorn","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","article-title":"Malignancy in neurofibromatosis type 1","volume":"5","author":"Korf","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1750-1172-8-127","article-title":"Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review","volume":"8","author":"Zehou","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2014.00324","article-title":"Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"4","author":"Kahn","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0190","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gcc.20921","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors","volume":"50","author":"Beert","year":"2011","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.22044","article-title":"Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis","volume":"33","author":"Upadhyaya","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0200","first-page":"849156.","article-title":"Frequent EGFR positivity and overexpression in high-grade areas of human MPNSTs","author":"Tabone-Eglinger","year":"2008","journal-title":"Sarcoma 2008"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1756-8722-6-93","article-title":"Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor","volume":"6","author":"Du","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-07-1305","article-title":"High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization","volume":"14","author":"Mantripragada","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0215","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1158\/1078-0432.CCR-11-0193","article-title":"Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors","volume":"17","author":"Torres","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0220","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2407-13-224","article-title":"Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivo through suppression of PDGFR-\u03b2","volume":"13","author":"Ohishi","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4161\/cbt.7.6.5932","article-title":"Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review","volume":"7","author":"Gudena","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0230","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-07-0518","article-title":"Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells","volume":"7","author":"Ambrosini","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40246-015-0025-3","article-title":"Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours","volume":"9","author":"Thomas","year":"2015","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0240","first-page":"5","article-title":"Vascular changes in cutaneous neurofibromas","volume":"1","author":"Teixeira","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0245","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MPH.0b013e3181e887c7","article-title":"The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1","volume":"32","author":"Gesundheit","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0250","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1158\/1541-7786.MCR-14-0182","article-title":"STAT3 and HIF1\u03b1 signaling drives oncogenic cellular phenotypes in malignant peripheral nerve sheath tumors","volume":"13","author":"Rad","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0255","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/2159-8290.CD-13-0081","article-title":"Canonical Wnt\/\u03b2-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance","volume":"3","author":"Watson","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0260","article-title":"The activation of the WNT signalling pathway is a hallmark in neurofibromatosis type 1 tumorigenesis","author":"Luscan","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0265","doi-asserted-by":"crossref","first-page":"e47595","DOI":"10.1371\/journal.pone.0047595","article-title":"Impaired Pten expression in human malignant peripheral nerve sheath tumours","volume":"7","author":"Bradtm\u00f6ller","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature13561","article-title":"PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies","volume":"514","author":"De Raedt","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0275","first-page":"113","article-title":"Identification of the polycomb group protein SU(Z) 12 as a potential molecular target for human cancer therapy","volume":"2","author":"Kirmizis","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0280","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1541-7786.MCR-12-0335","article-title":"SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK","volume":"10","author":"Li","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/molmed.2010.00079","article-title":"Identification of genes potentially involved in the increased risk of malignancy in NF1-microdeleted patients","volume":"17","author":"Pasmant","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0290","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1007\/s13277-014-1804-5","article-title":"SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis","volume":"35","author":"Liu","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0295","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"V\u00f6lkel","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-7364-6-23","article-title":"An emerging role for microRNAs in NF1 tumorigenesis","volume":"6","author":"Sedani","year":"2012","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0305","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/1471-2164-14-473","article-title":"MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis","volume":"14","author":"Masliah-Planchon","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0310","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0315","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/bjc.2012.518","article-title":"MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression","volume":"108","author":"Presneau","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcdb.2016.02.007_bib0320","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/path.2633","article-title":"Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours","volume":"220","author":"Subramanian","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.semcdb.2016.02.007_bib0325","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/neuonc\/nos124","article-title":"MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors","volume":"14","author":"Gong","year":"2012","journal-title":"Neuro. Oncol."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952116300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T02:46:26Z","timestamp":1600137986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952116300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":65,"alternative-id":["S1084952116300490"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.02.007","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis type 1: Fundamental insights into cell signalling and cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}